Yannick Doyon
Chercheur universitaire
Axe Oncologie
Publications
View all-
article Carleton GA, Levesque S, Zacharias LG, Patricio JS, Sutcliffe T, Watson PH, DeBerardinis RJ, Doyon Y, Lum JJ
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumors
bioRxiv 2025.
-
article Boccacci Y, Dumont N, Doyon Y, Laganière J
CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems
Hum Mol Genet 34 (12), 2025.
-
article Rivest JF, Carter S, Goupil C, Antérieux P, Cyr D, Ung RV, Dal Soglio D, Mac-Way F, Waters PJ, Paganelli M, Doyon Y
In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1
Genetics 228 (2), 2024.
Projects
- Regroupement Québécois de Recherche sur la Fonction, l’Ingénierie et les Applications des Protéines, from 2024-04-01 to 2030-03-31
- Correction génétique de la tyrosinémie héréditaire de type 1 chez la souris par ingénierie ciblée du génome, from 2024-10-01 to 2028-09-30
- In vivo genome editing for inborn errors of metabolism, from 2025-04-01 to 2030-03-31
- Orthologous CRISPR-Cas9 systems for genome editing: discovery, characterization and development for novel biotechnological applications, from 2019-10-01 to 2024-09-30